Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johanna Engelhard

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Free Radical Biology & Medicine|February 8, 2011
In situ kinetic trapping reveals a fingerprint of reversible protein thiol oxidation in the mitochondrial matrixJohanna Engelhard, Brooke E Christian, Lars Weingarten, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Multiple sclerosis by phenotype in GermanyJohanna Engelhard, Denise M Oleske, Sarah Schmitting, et al.
Psychiatry Research|January 13, 2018
Increased depression symptom score in newly diagnosed type 2 diabetes patientsWolfgang Rathmann, Oliver Kuß, Dörte Anderson, et al.
The EMBO Journal|June 9, 2007
Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1Ulla Schwertassek, Yves Balmer, Marcus Gutscher, et al.
ESC Heart Failure|October 30, 2020
Heart failure signs and symptoms, hospital referrals, and prescription patterns in patients receiving sacubitril/valsartan in primary care and cardiologist settings in GermanyRolf Wachter, Sven Klebs, Bogdan Balas, et al.
European Journal of Heart Failure|April 12, 2019
Real-world treatment patterns of sacubitril/valsartan: a longitudinal cohort study in GermanyRolf Wachter, Ana F Fonseca, Bogdan Balas, et al.
Cancer Immunology, Immunotherapy : CII|July 28, 2007
Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cellsDespina Rudolf, Tobias Silberzahn, Steffen Walter, et al.
Postgraduate Medicine|February 16, 2018
Early insights into the characteristics and evolution of clinical parameters in a cohort of patients prescribed sacubitril/valsartan in GermanyRolf Wachter, Daniel Viriato, Sven Klebs, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Free Radical Biology & Medicine|February 8, 2011
In situ kinetic trapping reveals a fingerprint of reversible protein thiol oxidation in the mitochondrial matrixJohanna Engelhard, Brooke E Christian, Lars Weingarten, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Multiple sclerosis by phenotype in GermanyJohanna Engelhard, Denise M Oleske, Sarah Schmitting, et al.
Psychiatry Research|January 13, 2018
Increased depression symptom score in newly diagnosed type 2 diabetes patientsWolfgang Rathmann, Oliver Kuß, Dörte Anderson, et al.
The EMBO Journal|June 9, 2007
Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1Ulla Schwertassek, Yves Balmer, Marcus Gutscher, et al.
ESC Heart Failure|October 30, 2020
Heart failure signs and symptoms, hospital referrals, and prescription patterns in patients receiving sacubitril/valsartan in primary care and cardiologist settings in GermanyRolf Wachter, Sven Klebs, Bogdan Balas, et al.
European Journal of Heart Failure|April 12, 2019
Real-world treatment patterns of sacubitril/valsartan: a longitudinal cohort study in GermanyRolf Wachter, Ana F Fonseca, Bogdan Balas, et al.
Cancer Immunology, Immunotherapy : CII|July 28, 2007
Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cellsDespina Rudolf, Tobias Silberzahn, Steffen Walter, et al.
Postgraduate Medicine|February 16, 2018
Early insights into the characteristics and evolution of clinical parameters in a cohort of patients prescribed sacubitril/valsartan in GermanyRolf Wachter, Daniel Viriato, Sven Klebs, et al.
Pageof 1